143 related articles for article (PubMed ID: 16823686)
21. Neuroleptics for behavioral symptoms of dementia.
Reynolds PL; Strayer SM
J Fam Pract; 2000 Jan; 49(1):78-9. PubMed ID: 10678345
[No Abstract] [Full Text] [Related]
22. Antipsychotics and risk of cerebrovascular events in treatment of behavioural and psychological symptoms of dementia in Hong Kong: a hospital-based, retrospective, cohort study.
Chan MC; Chong CS; Wu AY; Wong KC; Dunn EL; Tang OW; Chan WF
Int J Geriatr Psychiatry; 2010 Apr; 25(4):362-70. PubMed ID: 19650162
[TBL] [Abstract][Full Text] [Related]
23. A case-control study regarding relative factors for behavioural and psychological symptoms of dementia at a Canadian regional long-term extended care facility: a preliminary report.
Sawa M; Chan P; Donnelly M; McKenna M; Osaki Y; Kishimoto T; Ganesan S
Psychogeriatrics; 2014 Mar; 14(1):25-30. PubMed ID: 24397473
[TBL] [Abstract][Full Text] [Related]
24. Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia.
Onor ML; Saina M; Trevisiol M; Cristante T; Aguglia E
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):205-9. PubMed ID: 17020789
[TBL] [Abstract][Full Text] [Related]
25. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
26. The use of aromatherapy to treat behavioural problems in dementia.
Nguyen QA; Paton C
Int J Geriatr Psychiatry; 2008 Apr; 23(4):337-46. PubMed ID: 17918182
[TBL] [Abstract][Full Text] [Related]
27. An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia.
Tamrakar SM; Nepal MK; Koirala NR; Sharma VD; Gurung CK; Adhikari SR
Kathmandu Univ Med J (KUMJ); 2006; 4(2):152-60. PubMed ID: 18603890
[TBL] [Abstract][Full Text] [Related]
28. Management of behavioral and psychological symptoms of dementia in long-term care facilities in Japan.
Kutsumi M; Ito M; Sugiura K; Terabe M; Mikami H
Psychogeriatrics; 2009 Dec; 9(4):186-95. PubMed ID: 20377820
[TBL] [Abstract][Full Text] [Related]
29. Effect of Yi-Gan San on psychiatric symptoms and sleep structure at patients with behavioral and psychological symptoms of dementia.
Shinno H; Inami Y; Inagaki T; Nakamura Y; Horiguchi J
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):881-5. PubMed ID: 18243460
[TBL] [Abstract][Full Text] [Related]
30. Neither atypical nor conventional antipsychotics increase mortality or hospital admissions among elderly patients with dementia: a two-year prospective study.
Raivio MM; Laurila JV; Strandberg TE; Tilvis RS; Pitkälä KH
Am J Geriatr Psychiatry; 2007 May; 15(5):416-24. PubMed ID: 17463191
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
[TBL] [Abstract][Full Text] [Related]
32. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors.
Sankaranarayanan J; Puumala SE
Clin Ther; 2007 Apr; 29(4):723-41. PubMed ID: 17617297
[TBL] [Abstract][Full Text] [Related]
33. [Neuroleptics in psychogeriatrics. Evaluation of a treatment proposal].
Willekens-Bogaers MA; Smits GW
Tijdschr Gerontol Geriatr; 1990 Jul; 21(3):99-107. PubMed ID: 1974367
[TBL] [Abstract][Full Text] [Related]
34. [Behavioural and psychological symptoms in dementia].
Selbaek G
Tidsskr Nor Laegeforen; 2005 Jun; 125(11):1500-2. PubMed ID: 15940318
[TBL] [Abstract][Full Text] [Related]
35. Management of behavioral and psychological symptoms of dementia in a dedicated psychogeriatric unit: a pilot experience.
Koskas P; Feugeas MC; Saad S; Belqadi S; Daraux J; Drunat O
Alzheimer Dis Assoc Disord; 2011; 25(2):184-6. PubMed ID: 21606906
[TBL] [Abstract][Full Text] [Related]
36. Neuroleptic treatment effect on mitochondrial electron transport chain: peripheral blood mononuclear cells analysis in psychotic patients.
Casademont J; Garrabou G; Miró O; López S; Pons A; Bernardo M; Cardellach F
J Clin Psychopharmacol; 2007 Jun; 27(3):284-8. PubMed ID: 17502776
[TBL] [Abstract][Full Text] [Related]
37. The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia.
Engelborghs S; Vloeberghs E; Le Bastard N; Van Buggenhout M; Mariën P; Somers N; Nagels G; Pickut BA; De Deyn PP
Neurochem Int; 2008 May; 52(6):1052-60. PubMed ID: 18093695
[TBL] [Abstract][Full Text] [Related]
38. N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study.
Szulc A; Galińska B; Tarasów E; Kubas B; Dzienis W; Konarzewska B; Poplawska R; Tomczak AA; Czernikiewicz A; Walecki J
Med Sci Monit; 2007 May; 13 Suppl 1():17-22. PubMed ID: 17507880
[TBL] [Abstract][Full Text] [Related]
39. Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia.
Rémillard S; Pourcher E; Cohen H
J Int Neuropsychol Soc; 2008 Jan; 14(1):110-8. PubMed ID: 18078537
[TBL] [Abstract][Full Text] [Related]
40. Melperone, an aytpical antipsychotic drug with clozapine-like effect on plasma prolactin: contrast with typical neuroleptics.
Bobo WV; Jayathilake K; Lee MA; Meltzer HY
Hum Psychopharmacol; 2009 Jul; 24(5):415-22. PubMed ID: 19551763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
